Clinical Trials Directory

Trials / Sponsors / aTyr Pharma, Inc.

aTyr Pharma, Inc.

Industry · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (S
Interstitial Lung Disease
Phase 22023-10-26
Active Not RecruitingEfficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Pulmonary Sarcoidosis
Phase 32022-09-15
CompletedStudy to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Rela
SARS-CoV-2 (COVID-19) Severe Pneumonia
Phase 22020-06-04
CompletedStudy of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis
Pulmonary Sarcoidosis
Phase 1 / Phase 22019-01-29
CompletedStudy to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With
Facioscapulohumeral Muscular Dystrophy, Limb Girdle Muscular Dystrophy
Phase 1 / Phase 22016-07-13
CompletedEvaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscu
Facioscapulohumeral Muscular Dystrophy (FSHD)
Phase 1 / Phase 22016-03-30
CompletedEvaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LG
Limb-Girdle Muscular Dystrophies, Facioscapulohumeral Muscular Dystrophy
Phase 1 / Phase 22015-11-30
CompletedSafety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy
Facioscapulohumeral Muscular Dystrophy
Phase 1 / Phase 22015-08-13
CompletedSafety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscula
Facioscapulohumeral Muscular Dystrophy (FSHD)
Phase 1 / Phase 22014-09-04